210 related articles for article (PubMed ID: 27839836)
1. Different antiviral effects of IFNα and IFNβ in an HBV mouse model.
Zhou Y; Li S; Tang Z; Xu C; Huang S; Wu J; Dittmer U; Dickow J; Sutter K; Lu M; Yang D; Song J
Immunobiology; 2017 Mar; 222(3):562-570. PubMed ID: 27839836
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
5. Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.
Song J; Li S; Zhou Y; Liu J; Francois S; Lu M; Yang D; Dittmer U; Sutter K
Sci Rep; 2017 Mar; 7(1):334. PubMed ID: 28336921
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
Rang A; Günther S; Will H
J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
[TBL] [Abstract][Full Text] [Related]
7. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
9. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
[TBL] [Abstract][Full Text] [Related]
10. Establishment and primary application of a mouse model with hepatitis B virus replication.
Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H
World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401
[TBL] [Abstract][Full Text] [Related]
11. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
12. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
[TBL] [Abstract][Full Text] [Related]
13. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.
Furutani Y; Toguchi M; Shiozaki-Sato Y; Qin XY; Ebisui E; Higuchi S; Sudoh M; Suzuki H; Takahashi N; Watashi K; Wakita T; Kakeya H; Kojima S
PLoS One; 2019; 14(6):e0216139. PubMed ID: 31188831
[TBL] [Abstract][Full Text] [Related]
14. Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
Guo K; Shen G; Kibbie J; Gonzalez T; Dillon SM; Smith HA; Cooper EH; Lavender K; Hasenkrug KJ; Sutter K; Dittmer U; Kroehl M; Kechris K; Wilson CC; Santiago ML
PLoS Pathog; 2020 Oct; 16(10):e1008986. PubMed ID: 33064743
[TBL] [Abstract][Full Text] [Related]
15. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
17. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
18. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
[TBL] [Abstract][Full Text] [Related]
19. IFNA2 p.Ala120Thr impairs the inhibitory activity of Interferon-α2 against the hepatitis B virus through altering its binding to the receptor.
Chen C; Zhu X; Xu W; Yang F; Zhang G; Wu L; Zheng Y; Gao Z; Xie C; Peng L
Antiviral Res; 2017 Nov; 147():11-18. PubMed ID: 28958921
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies.
Ji C; Sastry KS; Tiefenthaler G; Cano J; Tang T; Ho ZZ; Teoh D; Bohini S; Chen A; Sankuratri S; Macary PA; Kennedy P; Ma H; Ries S; Klumpp K; Kopetzki E; Bertoletti A
Hepatology; 2012 Dec; 56(6):2027-38. PubMed ID: 22684948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]